Soleno and Acadias drugs for PWS specifically target hyperphagia whereas NNZ2591 impacts the syndrome broadly. As our two drugs do for all 6 syndromes we currently target and the infinite number thereafter…. There is no reason our drug cannot be taken in conjunction with the others to treat PWS.
These are not the exact words JP used when I asked him … but it summarises his thoughts.
Bring on 2024!
- Forums
- ASX - By Stock
- Neuren Media and Analyst Coverage
Soleno and Acadias drugs for PWS specifically target hyperphagia...
-
- There are more pages in this discussion • 683 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$15.52 |
Change
0.310(2.04%) |
Mkt cap ! $1.983B |
Open | High | Low | Value | Volume |
$15.19 | $15.62 | $15.11 | $8.655M | 558.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 440 | $15.48 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.54 | 752 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 440 | 15.480 |
1 | 175 | 15.350 |
1 | 708 | 15.210 |
3 | 6677 | 15.200 |
1 | 330 | 15.150 |
Price($) | Vol. | No. |
---|---|---|
15.610 | 5000 | 1 |
15.700 | 250 | 1 |
15.900 | 2000 | 1 |
15.980 | 26038 | 1 |
16.000 | 20 | 1 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online